Related Experiment Video
Updated: Jul 6, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Long-Term Outcomes of Concomitant Modified Cox-Maze and Mitral Surgery
Choosak Kasemsarn1, Pramote Porapakkham1, Sahaporn Wathanawanichakun1
1Department of Cardiothoracic Surgery, Central Chest Institute of Thailand, Nonthaburi, Thailand.
Insights
Combined Maze and mitral valve surgery effectively manages atrial fibrillation (AF) and mitral disease. Achieving sinus rhythm (SR) post-surgery reduces neurological complications, though recurrence predictors include AF duration and left atrial size.
Area of Science:
- Cardiovascular Surgery
- Cardiac Electrophysiology
- Thoracic Surgery
Background:
- Limited long-term data exists for combined Maze and mitral valve procedures.
- Atrial fibrillation (AF) management alongside mitral valve disease requires effective surgical solutions.
Purpose of the Study:
- To evaluate the long-term efficacy of combined Maze and mitral valve surgery.
- To identify predictors of AF recurrence and factors influencing survival after the procedure.
Main Methods:
- Analysis of 406 patients undergoing mitral surgery with concomitant Maze procedure (June 2004 - December 2022).
- Assessment of rhythm outcomes, AF recurrence predictors, and overall survival.
- Median follow-up of 100 months.
Main Results:
- Freedom from AF at 15 years was 52.7%.
- Sinus rhythm (SR) patients had fewer neurological complications compared to those in AF (p=0.001).
- Predictors of AF recurrence included longer AF duration, left atrial diameter >50 mm, tricuspid valve surgery, and early postoperative AF.
Conclusions:
- Combined Maze and mitral valve surgery offers significant benefits for patients with AF and mitral disease.
- Early identification of recurrence predictors like AF duration and left atrial size is crucial.
- Maintaining SR post-surgery is associated with improved neurological outcomes.
Purpose:
There are limited data on outcomes of combined Maze and mitral valve procedures beyond 10 years. This study analyzed the efficacy of this operation.
Methods:
Between June 2004 and December 2022, 406 patients underwent mitral surgery concomitant with Maze procedure were evaluated. Rhythm outcomes, predictors of recurrence, and survival were assessed.
Results:
The median follow-up period was 100 months. Rheumatic disease was present in 58%. Mitral valve repair was performed in 57.1%. Freedom from atrial fibrillation (AF) at 5, 10, and 15 years was 82.5%, 70.8%, and 52.7%, respectively. Overall survival rates were not different between patients in sinus rhythm (SR) and those who remained in AF (p = 0.172). However, patients in SR experienced fewer neurological complication (p = 0.001). Predictors of AF recurrence included preoperative AF duration (p = 0.005), left atrial diameter (LAD) >50 mm (p <0.001), concomitant tricuspid valve surgery (p = 0.049), and the presence of AF on postoperative day 7 (p <0.001). Factors influencing survival were age >60 years (p <0.001) and a postoperative left ventricular ejection fraction <40% (p <0.001).
Conclusions:
The combined Maze and mitral valve surgery provides significant benefits in managing AF with mitral disease. Predictors of recurrence included AF duration, LAD size >50 mm, associated tricuspid valve disease, and AF on day 7. SR patients had fewer neurological complications.
More Related Videos
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis III: Medical Management
Mitral Stenosis IV: Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management

